Blog Band - Page 42 of 300

23

Jul 2025

HMNC Brain Health and Spruce Biosciences Dose First Patient in P-II (TAMARIND) Trial of Tildacerfont for Major Depressive Disorder

Shots: HMNC & Spruce has dosed the first pts with tildacerfont in P-II (TAMARIND) trial for the treatment of major depressive disorder (MDD) The P-II (TAMARIND) trial will assess tildacerfont…

23

Jul 2025

NEWS

Slingshot AI launches Ash for Personalized Mental Health Support

Shots: Slingshot AI has launched Ash, a personalized mental health support app, which is now available on both iOS & Android platforms Slingshot AI also secured a Series A extension…

23

Jul 2025

NEWS

Roche’s Itovebi Regimen Secures the EC’s Approval for PIK3CA-mutated Breast Cancer

Shots: The EC has approved Itovebi + Ibrance & fulvestrant as a 1L therapy for adults with PIK3CA-mutated, ER+/HER2- locally advanced or metastatic breast cancer recurring on or within 12mos.…

22

Jul 2025

VIDEO

LIFE SCIENCES | DAILY NEWS | JUN 22, 2025 | PHARMASHOTS

22

Jul 2025

INSIGHTS+

EMA Marketing Authorization of New Drugs in June 2025

Shots: The EMA’s CHMP has granted positive opinions and approvals to 2 Biologics and 6 new chemical entities in June 2025, leading to treatments for patients and advances in the…

22

Jul 2025

NEWS

Concentra Biosciences Enters a Merger Agreement to Acquire iTeos Therapeutics

Shots: Concentra Biosciences has entered into a definitive merger agreement to acquire iTeos Therapeutics As per the deal, iTeos Therapeutics’ shareholders will receive $10.047 per share in cash, along with…

22

Jul 2025

NEWS

Merck’s Keytruda Regimen Receives Health Canada’s Approval for FIGO 2014 Stage III-IVA Cervical Cancer

Shots: Health Canada has approved Keytruda + chemoradiotherapy (CRT) for the treatment of adults with FIGO 2014 Stage III-IVA cervical cancer Approval was based on P-III (KEYNOTE-A18/ ENGOT-cx11/GOG-3047) trial assessing…

22

Jul 2025

NEWS

Medtronic Reports the European CE Mark of MiniMed 780G System for Automated Insulin Delivery

Shots: Medtronic has received CE mark to extend label of MiniMed 780G system to pts (≥2yrs.), pregnant women & T2D pts; application is under the FDA’s review for T2D, plus…

22

Jul 2025

NEWS

Bavarian Nordic Reports the Health Canada’s NDS Acceptance of CHIKV VLP to Prevent Chikungunya

Shots: Health Canada has accepted NDS of CHIKV VLP for active immunization against CHIKV disease in individuals (≥12yrs.); decision is anticipated in H1’26 NDS was based on 2 P-III trials…

22

Jul 2025

NEWS

Sanofi to Acquire Vicebio for ~$1.6B

Shots: Sanofi has entered into an agreement to acquire Vicebio, expanding its respiratory vaccines pipeline & capabilities with Vicebio’s vaccine candidates (VXB-241 & VXB-251) & Molecular Clamp tech As per…

HMNC Brain Health and Spruce Biosciences Dose First Patient in P-II (TAMARIND) Trial of Tildacerfont for Major Depressive Disorder

Slingshot AI launches Ash for Personalized Mental Health Support

Roche’s Itovebi Regimen Secures the EC’s Approval for PIK3CA-mutated Breast Cancer

LIFE SCIENCES | DAILY NEWS | JUN 22, 2025 | PHARMASHOTS

EMA Marketing Authorization of New Drugs in June 2025

Concentra Biosciences Enters a Merger Agreement to Acquire iTeos Therapeutics

Merck’s Keytruda Regimen Receives Health Canada’s Approval for FIGO 2014 Stage III-IVA Cervical Cancer

Medtronic Reports the European CE Mark of MiniMed 780G System for Automated Insulin Delivery

Bavarian Nordic Reports the Health Canada’s NDS Acceptance of CHIKV VLP to Prevent Chikungunya

Sanofi to Acquire Vicebio for ~$1.6B

Contact US

OUR INFORMATION

FOLLOW US